Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Sciences de la vie et Santé

Word on the street at the J.P. Morgan Healthcare Conference 2024

17 janvier 2024
In-depth analysis

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Advising gene therapy company AlveoGene on its complex spinout and launch investment

23 octobre 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Lingotto-led investors on chip developer Optalysys Series A funding

24 juillet 2023

par plusieurs auteurs

Cliquer ici pour en savoir plus
Gaming

Advising BITKRAFT Ventures on its investment in Scriptic

3 juillet 2023

par Richard Faichney et Ross McNaughton

Cliquer ici pour en savoir plus